These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 9806728

  • 21. Hemorheological mechanisms in Alzheimer's disease.
    Chang CY, Liang HJ, Chow SY, Chen SM, Liu DZ.
    Microcirculation; 2007 Aug; 14(6):627-34. PubMed ID: 17710633
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
    Feher G, Koltai K, Kesmarky G, Horvath B, Toth K, Komoly S, Szapary L.
    Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Hemorheological parameters and aging.
    Feher G, Koltai K, Kesmarky G, Szapary L, Juricskay I, Toth K.
    Clin Hemorheol Microcirc; 2006 Mar; 35(1-2):89-98. PubMed ID: 16899911
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Hemorheological parameters in children with iron-deficiency anemia and the alterations in these parameters in response to iron replacement.
    Halis H, Bor-Kucukatay M, Akin M, Kucukatay V, Bozbay I, Polat A.
    Pediatr Hematol Oncol; 2009 Mar; 26(3):108-18. PubMed ID: 19382032
    [Abstract] [Full Text] [Related]

  • 28. [Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients].
    Szapáry L, Szóts M, Horváth B, Márton Z, Alexy T, Késmárky G, Juricskay I, Nagy F, Gaál V, Pálfi A, Koltai K, Tóth K.
    Orv Hetil; 2003 Jun 01; 144(22):1085-90. PubMed ID: 12847818
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The hemorheological effects of raloxifene in postmenopausal women with osteoporosis. Results of a 3-year placebo-controlled clinical trial.
    Shand B, Gilchrist N, Blackwell T, March R.
    Clin Hemorheol Microcirc; 2002 Jun 01; 26(4):249-55. PubMed ID: 12122230
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effects of doxazosin on hemorheological, hemodynamic and lipid parameters in patients with essential hypertension.
    Toth K, Nemes J, Czopf L, Kapronczay P, Kesmarky G, Juricskay I.
    Clin Hemorheol Microcirc; 1999 Jun 01; 20(1):57-61. PubMed ID: 11185685
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.